Dr. Moschos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
170 Manning Drive
3116
Chapel Hill, NC 27514Phone+1 919-843-7713- Is this information wrong?
Summary
- Melanoma medical oncology. Late preclinical, early clinical development. Non-invasive biomarkers of response to immune checkpoint inhibitors. Immuno-metabolism. Central thymic tolerance. Brain metastases
Education & Training
- University of AthensClass of 1997
Certifications & Licensure
- NC State Medical License 2011 - 2024
- PA State Medical License 2002 - 2012
Clinical Trials
- A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors Start of enrollment: 2020 Aug 17
Roles: Principal Investigator
Publications & Presentations
PubMed
- Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy.Jacob Hall, Kevin Lui, Xianming Tan, John Shumway, Frances Collichio, Stergios Moschos, Soma Sengupta, Rekha Chaudhary, Carolyn Quinsey, Sivakumar Jaikumar, Jonathan F...> ;Radiotherapy and Oncology. 2023 Dec 1
- 5 citationsMulti-organ landscape of therapy-resistant melanoma.Sixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, Yan Wang, Xiao Zhang, Zhentao Yang, Raymond J Lim, Camelia Dumitras, Philip O Scumpia, Steve M Dubinett, Gatien...> ;Nature Medicine. 2023 May 1
- 3 citationsDevelopment of [F]F-5-OMe-Tryptophans through Photoredox Radiofluorination: A New Method to Access Tryptophan-Based PET Agents.Xuedan Wu, Xinrui Ma, Yaofeng Zhong, Wei Chen, Muyun Xu, He Zhang, Li Wang, Xianshuang Tu, Zhaoguo Han, Weiling Zhao, Zhanhong Wu, Stergios J Moschos, Zibo Li> ;Journal of Medicinal Chemistry. 2023 Mar 9
- Join now to see all
Press Mentions
- Researchers Study Genetic Changes in Tumors of Recently Deceased Patients with MelanomaMay 2nd, 2023
- Researchers Identify Lethal Molecular Alterations After Current Therapies Fail Patients with Metastatic MelanomaApril 27th, 2023
- Cancer’s Capacity to Resist Treatment ThwartedJanuary 27th, 2023
- Join now to see all
Hospital Affiliations
- University of North Carolina HospitalsChapel Hill, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: